Background: Information on the relationship between the presence of cerebral microbleeds (CMB) and the body weight is inconsistent. Moreover, studies have been limited to Asian and White populations. We aimed at assessing the association between CMB and the body mass index (BMI) in an indigenous South American population. Methods: CMB were identified by gradient-echo MRI and the BMI was calculated in community dwellers aged ≥60 enrolled in the Atahualpa Project. The association between CMB and the BMI was examined in logistic regression models adjusted for relevant confounders. Results: CMB were recognized in 41 (13%) out of 311 participants. These individuals were older, more often hypertensive, had a worse diet, had more severe white matter hyperintensities and strokes than those without CMB. Anthropometric measurements were 148 ± 9 cm for height, 58 ± 12 kg for weight, and 26.7 ± 5 kg/m2 for the BMI. Multivariate models showed no association between the presence of CMB and the BMI (OR 0.97; 95% CI 0.89-1.05; p = 0.508). Analyses with CMB categorized according to their location did not show associations between strictly lobar or deep CMB and the BMI. Conclusion: The presence of CMB is unrelated to abnormal BMI determinations in Ecuadorian natives/mestizos.

1.
Fisher M, French S, Ji P, Kim RC: Cerebral microbleeds in the elderly: a pathological analysis. Stroke 2010;41:2782-2785.
2.
Lee SH, Bae HJ, Kwon SJ, Kim H, Kim YH, Yoon BW, et al: Cerebral microbleeds are regionally associated with intracerebral hemorrhage. Neurology 2004;62:72-76.
3.
Wu R, Feng C, Zhao Y, Jin AP, Fang M, Liu X: A meta-analysis of association between cerebral microbleeds and cognitive impairment. Med Sci Monit 2014;20:2189-2198.
4.
Yates PA, Villemagne VL, Ellis KA, Desmond PM, Masters CL, Rowe CC: Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations. Front Neurol 2014;4:205.
5.
Albanese E, Davis B, Jonsson PV, Chang M, Aspelund T, Garcia M, et al: Overweight and obesity in midlife and brain structure and dementia 26 years later: the AGES-Reykjavik study. Am J Epidemiol 2015;181:672-679.
6.
Ding J, Sigurdsson S, Garcia M, Phillips CL, Eiriksdottir G, Gudnason V, et al: Risk factors associated with incident cerebral microbleeds according to location in older people: the age, gene/environment susceptibility (AGES)-Reykjavik study. JAMA Neurol 2015;72:682-688.
7.
Kim CK, Kwon HM, Lee SH, Kim BJ, Ryu WS, Kwon HT, et al: Association of obesity with cerebral microbleeds in neurologically asymptomatic elderly subjects. J Neurol 2012;259:2599-2604.
8.
Yamada S, Satow T, Fukuda A, Ito M, Saiki M: Severe underweight and cerebral microbleeds. J Neurol 2012;259:2707-2713.
9.
Del Brutto OH, Peñaherrera E, Ochoa E, Santamaría M, Zambrano M, Del Brutto VJ; Atahualpa Project Investigators: Door-to-door survey of cardiovascular health, stroke, and ischemic heart disease in rural coastal Ecuador - the Atahualpa Project: methodology and operational definitions. Int J Stroke 2014;9:367-371.
10.
Castillo PR, Mera RM, Zambrano M, Del Brutto OH: Population-based study of facial morphology and excessive daytime somnolence. Pathophysiology 2014;21:289-292.
11.
World Health Organization: Waist Circumference and Waist-Hip Ratio. Report of a WHO Expert Consultation, Geneva, 8-11 December 2008. Geneva, WHO Document Production Services.
12.
Del Brutto OH, Mera RM, Del Brutto VJ, Zambrano M, Lama J: White matter hyperintensities of presumed vascular origin: a population-based study in rural Ecuador (the Atahualpa project). Int J Stroke 2015;10:372-375.
13.
Gregoire SM, Chaudhary UJ, Brown MM, Yousry TA, Kallis C, Jager HR, et al: The microbleed anatomical rating scale (MARS): reliability of a tool to map brain microbleeds. Neurology 2009;73:1759-1766.
14.
Del Brutto OH, Lama J, Zambrano M, Del Brutto VJ: Neurocysticercosis is a neglected microbleed mimic. A cautionary note for stroke neurologists. Eur Neurol 2014;72:306-308.
15.
Pantoni L, Basile AM, Pracucci G, Asplund K, Bogousslavsky J, Chabriat H, et al: Impact of age-related cerebral white matter changes on the transition to disability - the LADIS study: rationale, design and methodology. Neuroepidemiology 2005;24:51-62.
16.
Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al: Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12:822-838.
17.
Pasquier F, Leys D, Weerts JG, Mounier-Vehier F, Barkhof F, Scheltens P: Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol 1996;36:268-272.
18.
Zhou JF, Wang JY, Luo YE, Chen HH: Influence of hypertension, lipometabolism disorders, obesity and other lifestyles on spontaneous intracerebral hemorrhage. Biomed Environ Sci 2003;16:295-303.
19.
Del Brutto OH, Mera RM, Ha JE, Del Brutto VJ, Castillo PR, Zambrano M, et al: Oily fish consumption is inversely correlated with cerebral microbleeds in community-dwelling older adults: results from the Atahualpa project. Aging Clin Exp Res 2015, Epub ahead of print.
20.
Lin WY, Lee LT, Chen CY, Lo H, Hsia HH, Liu IL, et al: Optimal cut-off values for obesity: using simple anthropometric indices to predict cardiovascular risk factors in Taiwan. Int J Obes Relat Metab Disord 2002;26:1232-1238.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.